You just read:

Hovione Announces Start of Phase 1 Clinical Trial of HY02, a Proprietary Minocycline Sterile Ointment to Treat a Subset of Anterior Ocular Inflammation

News provided by

Hovione

May 25, 2017, 09:00 ET